参考文献/References:
[1] 姜敏,吴荣.放射性心脏损伤的研究进展[J].医学综述,2012,18(19):3228-3231.
[2] 孙华斌,于秀欣.辐射生物效应多样性的统一辐射剂量生物效应理论模型和应用研究[J].中国辐射卫生,2013,22(1):5-7.
[3] Keller L,Cohen R,Sopka DM,et al.Effect of Bra Use during Radiotherapy for Large-Breasted Women:Acute Toxicity and Treated Heart and Lung Volumes[J].Pract Radiat Oncol,2013,3(1):9-15.
[4] Stewart FA,Seemann I,Hoving S,et al.Understanding radiation-induced cardiovascular damage and strategies for intervention[J].Clin Oncol(R Coll Radiol),2013,25(10):617-624.
[5] 杜向慧,王升晔.恶性肿瘤患者放化疗相关的心脏毒性损伤[J].中华心血管病杂志,2012,40(11):982-983.
[6] Cardinale D,Colombo A,Lamantia G,et al.Anthracycline-induced cardiomyopathy:clinical relevance and response to pharmacologic therapy[J],J Am Coll Cardiol,2010,55(3):213-220.
[7] 王振华.ET技术评价头颈部肿瘤放疗早期患者颈动脉弹性的临床研究[D].郑州:郑州大学,2011.
[8] 钱普东,郭文杰,何侠.头颈部恶性肿瘤放疗与颈动脉狭窄的关系[J].肿瘤学杂志,2012,18(1):25-28.
[9] 曹杰红,谭华清.左卡尼汀预防放疗所致肺癌患者心脏损伤的效果观察[J].肿瘤药学,2013,3(4):290-292.
[10] 刘平,马进安,朱道奇,等.左卡尼汀对乳腺癌化放疗心脏毒性的保护[J].中华普通外科杂志,2008,23(12):977-978.
[11] Fene M,Smith DE,Normolle DP,et al.A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy[J].Int J Radiat Oncol Biol Phys,2012,83(5):1441-1447.
[12] Boerma M,Roberto KA,Hauer-Jensen M.Prevention and treatment of functional and structural radiation injury in the rat heart by pentoxifylline and alpha-tocopherol[J].Int J Radiat Oncol Biol Phys,2008,72(1):170-177.
[13] Liu H,Xiong M,Xia YF,et al.Studies on pentoxifylline and tocopherol combination for radiation-induced heart disease in rats[J].Int J Radiat Oncol Biol Phys,2009,73(5):1552-1559.
[14] 吕鹏,臧爱民.血清肌钙蛋白I在放射性心脏损伤中的变化及右丙亚胺对其影响[J].长治医学院学报,2013,27(2):94-96.
[15] Davis TA,Landauer MR,Mog SR,et al.Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation[J].Exp Hematol,2010,38(4):270-281.
[16] Hiona A,Lee AS,Nagendran J,et al.Pretreatment with angiotensin-converting enzyme inhibitor improves doxorubicin-induced cardiomyopathy via preservation of mitochondrial function[J].J Thorac Cardiovasc Surg,2011,142(2):396-403.
[17] Darby SC,Cutter DJ,Boerma M,et al.Radiation-related heart disease:current knowledge and future prospects[J].Int J Radiat Oncol Biol Phys,2010,76(3):656-665.
[18] 陈小平,郑新萍,冯惠芳,等.地尔硫唑对放射损伤心肌的保护作用[J].心脏杂志,2007,19(2):209-211.
[19] 徐庆瑞,潘元成.核糖防治放射性心脏损伤疗效观察[J].中国实用医刊,2008,35(13):36-37.
[20] 吕守超.放射性心脏损伤及防护[J].中国药物经济学,2013,8(S2):332-333.
[21] 张海涛,郭雅,曹成明,等.1,6-二磷酸果糖在肿瘤诊疗中的应用进展[J].广东医学,2013,34(9):1451-1453.
[22] Martinez EC,Kofidis T.Adult stem cells for cardiac tissue engineering[J].J Mol Cell Cardiol,2011,50(2):312-319.
[23] Wang T,Sun S,Wan Z,et al.Effects of bone marrow mesenchymal stem cells in a rat model of myocardial infarction[J].Resuscitation,2012,83(11):1391-1396.
[24] Cheng Y,Hu R,Lv L,et al.Erythropoietin improves the efficiency of endothelial progenitor cell therapy after myocardial infarction in mice:effects on transplanted cell survival and autologous endothelial progenitor cell mobilization[J].J Surg Res,2012,176(1):e47-55.
[25] Agay D,Scherthan H,Forcheron F,et al.Multipotent mesenchymal stem cell grafting to treat cutaneous radiation syndrome:development of a new minipig model[J].Exp Hematol,2010,38(10):945-956.
[26] Barcellos LM,Costa WS,Medeiros JL Jr,et al.Protective effects of 1-glutamine on the bladder wall of rats submitted to pelvic radiation[J].Micron,2013,47(1):18-23.
[27] 刘灵芝.复方丹参滴丸对肺癌患者放疗所致心脏损伤的保护作用[J].肿瘤基础与临床,2012,25(5):440-441.
[28] 屈强.黄芪注射液对放射性心脏损伤的保护作用[J].肿瘤基础与临床,2012,25(4):356-357.
[29] 刘建民,李东风.麝香保心丸对放射性心功能损伤的保护作用观察[J].中国误诊学杂志,2010,10(30):7396.
[30] 何丹,吴玉.放射性肺炎的诊断与治疗[J].吉林医学,2013,34(11):2129-2130.
[31] 魏青,钱普东,蒋鸣.天芝草胶囊对肺癌放疗后心脏损伤的保护作用观察[J].中医药导报,2010,16(5):35-36.
[32] 陈秀珍,朱大诚,王艳辉.白花蛇舌草药理作用及临床应用研究新进展[J].中药材,2009,32(1):157-161.
相似文献/References:
[1]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[2]刘佳,高刚,朴春南,等.调节肿瘤放射敏感性的miRNAs研究进展[J].国际放射医学核医学杂志,2016,40(2):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
Liu Jia,Gao Gang,Piao Chunnan,et al.Progress of microRNAs in regulating tumor radiation sensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
[3]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[4]赵德云,李百龙.植物提取物防治放射性肺损伤的现状与展望[J].国际放射医学核医学杂志,2016,40(3):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
Zhao Deyun,Li Bailong.Protective and therapeutic effects of plant extracts on radiation-induced lung injury:present status and future prospects[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
[5]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[6]邓大平,卢峰,孙洪强,等.颅脑肿瘤放射治疗时射野外器官吸收剂量体模法测量与分析[J].国际放射医学核医学杂志,2016,40(4):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
Deng Daping,Lu Feng,Sun Hongqiang,et al.Test and analysis of out-of-field organ dose in intracranial tumor radiotherapy using phantom[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
[7]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[8]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[9]段永璇,邹晓艳,段秀梅,等.数据解析在肿瘤放射治疗中的应用[J].国际放射医学核医学杂志,2015,39(6):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
Duan Yongxuan,Zou Xiaoyan,Duan Xiumei,et al.Data analysis in the field of tumor radiation therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
[10]贾立立,孟粹达,刘晓冬,等.头颈部肿瘤放疗中转化医学相关机制的研究进展[J].国际放射医学核医学杂志,2015,39(3):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
Jia Lili,Meng Cuida,Liu Xiaodong,et al.Development in translational medicine-related mechanisms of radiotherapy for head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]